Piscataqua Savings Bank’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-250
Closed -$407 350
2024
Q2
$407 Hold
250
﹤0.01% 341
2024
Q1
$1.28K Hold
250
﹤0.01% 369
2023
Q4
$1.43K Hold
250
﹤0.01% 335
2023
Q3
$1.19K Hold
250
﹤0.01% 343
2023
Q2
$1.06K Hold
250
﹤0.01% 335
2023
Q1
$1.33K Hold
250
﹤0.01% 339
2022
Q4
$1.57K Hold
250
﹤0.01% 324
2022
Q3
$3K Hold
250
﹤0.01% 298
2022
Q2
$1K Hold
250
﹤0.01% 327
2022
Q1
$2K Buy
250
+100
+67% +$1.05K ﹤0.01% 329
2021
Q4
$2K Hold
150
﹤0.01% 323
2021
Q3
$4K Buy
+150
New +$3.67K ﹤0.01% 305

Other funds holding CRBU

Piscataqua Savings Bank's CRBU Position: Q3 2024 in Review

Piscataqua Savings Bank sold out of Caribou Biosciences (CRBU) in Q3 2024, closing a stake of 250 shares — an estimated $407 sold.

Piscataqua Savings Bank first reported a position in CRBU in Q3 2021 and held it in 12 quarters. The position peaked at $4K in Q3 2021. 129 funds tracked by Wall St. Rank hold CRBU as of Q3 2024.

  • Piscataqua Savings Bank reported no remaining Caribou Biosciences position as of Q3 2024 after selling out during the quarter.
  • Piscataqua Savings Bank sold 250 Caribou Biosciences shares in Q3 2024, an estimated $407.
  • Piscataqua Savings Bank first reported a position in Caribou Biosciences in Q3 2021 and held it in 12 quarters.
  • Piscataqua Savings Bank's Caribou Biosciences position peaked at $4K in Q3 2021.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2024.

Based on Piscataqua Savings Bank's 13F filing for Q3 2024, filed 15 Oct 2024.